Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirley H Lomeli

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of the American Society for Mass Spectrometry|December 23, 2008
Increasing charge while preserving noncovalent protein complexes for ESI-MSShirley H Lomeli, Sheng Yin, Rachel R Ogorzalek Loo, et al.
Journal of the American Society for Mass Spectrometry|October 27, 2009
New reagents for increasing ESI multiple charging of proteins and protein complexesShirley H Lomeli, Ivory X Peng, Sheng Yin, et al.
American Journal of Clinical and Experimental Immunology|November 29, 2017
Optimizing peptide epitope-based autoantibody detection in cancer patientsMaize Wang, Shirley H Lomeli, Wilbur A Franklin, et al.
American Journal of Clinical and Experimental Immunology|August 22, 2014
Dominant B-cell epitopes from cancer/stem cell antigen SOX2 recognized by serum samples from cancer patientsJulia Shih, Munira Rahman, Quang T Luong, et al.
Cancer Discovery|May 31, 2022
Enhancing PD-L1 Degradation by ITCH during MAPK Inhibitor Therapy Suppresses Acquired ResistanceZhentao Yang, Yan Wang, Sixue Liu, et al.
Journal of the American Society for Mass Spectrometry|April 17, 2007
Sizing large proteins and protein complexes by electrospray ionization mass spectrometry and ion mobilityCatherine S Kaddis, Shirley H Lomeli, Sheng Yin, et al.
Cancer Discovery|January 26, 2023
Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in MelanomaPrashanthi Dharanipragada, Xiao Zhang, Sixue Liu, et al.
Nature Medicine|April 27, 2023
Multi-organ landscape of therapy-resistant melanomaSixue Liu, Prashanthi Dharanipragada, Shirley H Lomeli, et al.
Immunity|November 1, 2025
Genomic copy-number variants drive apoptotic evasion underlying acquired resistance to immune checkpoint inhibitorsMingming Wu, Shiyue Yang, Zhentao Yang, et al.
Cancer|January 23, 2024
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancersAlain P Algazi, James Moon, Christopher D Lao, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of the American Society for Mass Spectrometry|December 23, 2008
Increasing charge while preserving noncovalent protein complexes for ESI-MSShirley H Lomeli, Sheng Yin, Rachel R Ogorzalek Loo, et al.
Journal of the American Society for Mass Spectrometry|October 27, 2009
New reagents for increasing ESI multiple charging of proteins and protein complexesShirley H Lomeli, Ivory X Peng, Sheng Yin, et al.
American Journal of Clinical and Experimental Immunology|November 29, 2017
Optimizing peptide epitope-based autoantibody detection in cancer patientsMaize Wang, Shirley H Lomeli, Wilbur A Franklin, et al.
American Journal of Clinical and Experimental Immunology|August 22, 2014
Dominant B-cell epitopes from cancer/stem cell antigen SOX2 recognized by serum samples from cancer patientsJulia Shih, Munira Rahman, Quang T Luong, et al.
Cancer Discovery|May 31, 2022
Enhancing PD-L1 Degradation by ITCH during MAPK Inhibitor Therapy Suppresses Acquired ResistanceZhentao Yang, Yan Wang, Sixue Liu, et al.
Journal of the American Society for Mass Spectrometry|April 17, 2007
Sizing large proteins and protein complexes by electrospray ionization mass spectrometry and ion mobilityCatherine S Kaddis, Shirley H Lomeli, Sheng Yin, et al.
Cancer Discovery|January 26, 2023
Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in MelanomaPrashanthi Dharanipragada, Xiao Zhang, Sixue Liu, et al.
Nature Medicine|April 27, 2023
Multi-organ landscape of therapy-resistant melanomaSixue Liu, Prashanthi Dharanipragada, Shirley H Lomeli, et al.
Immunity|November 1, 2025
Genomic copy-number variants drive apoptotic evasion underlying acquired resistance to immune checkpoint inhibitorsMingming Wu, Shiyue Yang, Zhentao Yang, et al.
Cancer|January 23, 2024
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancersAlain P Algazi, James Moon, Christopher D Lao, et al.
Pageof 2